India bans export of Remdesivir drug, injection till Covid situation improves

• 'There is a potential of a further increase in demand for Remdesivir injection in the coming days,' the Centre says
• Remdesivir is considered a key anti-viral drug in the fight against COVID-19, especially in adult patients with severe complications

• Infosys will report its March quarter earnings for FY21 on 14 April
• Meanwhile, Infosys added ₹23,625.36 crore to its total market valuation last week at ₹6,13,854.71 crore

• Out of almost 20 COVID-19 vaccines in various clinical and pre-clinical stages, Sputnik V vaccine will get the nod first
• India to have 5 more COVID vaccines by October, says top govt sources to ANI

The reversal of buying trend came after FPIs invested ₹17,304 crore in March, ₹23,663 crore in February and ₹14,649 crore in January.

• Delhi Chief Minister Arvind Kejriwal said that a full lockdown is not the solution to tackle the Covid-19 pandemic
• However, CM Kejriwal said that certain restrictions have been put in place to curb the recent spike in cases

Due to emergence of COVID-19 pandemic, there is an urgent need for liqudity in one's portfolio

Experts say that in next two to three months, gold price at Multi Commodity Exchange (MCX) may hit ₹49,000 per 10 gm